nance. It also brings us to the intersecting paths of self-renewal and cell survival. Indeed, the direct comparison of ESC and HSC self-renewal and survival programs will require a more complete characterization of their respective components.
Tothova, Z., Kollipara, R., Huntly, B.J., Lee, B.H., Castrillon, D.H., Cullen, D.E., McDowell, E.P., Lazo-Kallanian, S., Williams, I.R., Sears, C., et al. (2007) . Cell 128, [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] The regulation of metabolic processes requires that cells communicate with their neighbors to ensure an appropriate response to the changing environment. The pancreas is a classic example of a tissue that depends on intercellular communication among the same (autocrine) and/or different (paracrine) cell types. The human pancreas is composed of over a million islets, each islet comprising several thousand cells including primarily insulin-secreting β cells but also glucagon-secreting α cells, somatostatin-secreting δ cells, pancreatic polypeptide-secreting (PP) cells, and ghrelin-producing ε cells. Within each islet, the different endocrine cells are thought to communicate with each other, either extracellularly via secreted products or directly through cell junctions. A role for paracrine and autocrine communication in the regulation of islet secretory function was proposed decades ago (Halban et al., 1982) . For instance, insulin release from β cells can act on α cells to influence glucagon secretion, and somatostatin from δ cells acts as a paracrine inhibitor of neighboring α and β cells (Bonner-Weir and Orci, 1982; Samols and Stagner, 1990) . Although intercellular exchange between β cells through membrane channels was confirmed by electrophysiologic and metabolic coupling experiments, the proteins and signaling mechanisms that underlie the communication between these insulin-secreting cells remain unclear. In this issue, Konstantinova et al. (2007) reveal that signaling via an ephrin ligand and its Eph receptor mediate communication between β cells.
Receptor tyrosine kinases (RTKs) play an important role in communicating crucial information from the environment to the inside of the cell to modulate fundamental cellular processes. The Eph receptors constitute the largest family of RTKs, and, together with their plasma membranebound ephrin ligands, have multiple functions during development and adulthood. Ephrins are divided into two subclasses: the A-subclass ligands (ephrin-A1 through ephrin-A5) are tethered to the cell membrane by a glycosylphosphatidylinositol anchor, whereas the B-subclass ligands (ephrin-B1 through ephrin-B3) have a transmembrane domain followed by a short cytoplasmic region (Kullander and Klein, 2002) .
In contrast with most RTKs, the Eph family possesses a unique fea- How insulin-secreting β cells of the pancreas communicate with each other is largely unknown. In this issue of Cell, Konstantinova et al. (2007) show that the signaling proteins EphA and ephrin-A modulate insulin secretion, providing fresh insights into the functional significance of the clustering of β cells, which occurs in islets.
ture in that signaling can originate from either the ephrin ligands (termed reverse signaling) or from the Eph receptors (termed forward signaling). This bidirectional signaling has emerged as an important signature function by which Ephs and ephrins can control output signals, especially in processes requiring cell-to-cell communication. The Ephephrin system plays an important role in neuronal development and function, processes requiring precise cell migration to allow appropriate neuronal connections via cell-to-cell communication and secretory events in synapses. Perhaps it should not be surprising, therefore, that pancreatic β cells, which share neural ancestry, also use the Eph-ephrin system for their secretory function. Konstantinova et al. (2007) provide evidence that the Eph-ephrin system may form an important pathway for cell-tocell communication in the regulation of insulin secretion (Figure 1 ). The authors observed the expression of both A and B classes of ephrins and Ephs-with an abundance of EphA and ephrin-A-in both mouse and human islets. The authors built on this initial observation by using immunohistochemistry to demonstrate that ephrins and Ephs are expressed in areas of cell-cell contact, but not on free surfaces of insulinomaderived MIN6 β cells. Subsequently, using fusion protein ligands that can activate ephrin-A5 (EphA5-Fc) or EphA5 (ephrin-A5-Fc) signalling, the authors demonstrated that ephrin-A5 reverse signaling promoted and EphA5 forward signaling inhibited glucose-stimulated insulin secretion, and these effects were dependent on β cells being in contact with each other.
Studies in other cell types indicate that EphA-ephrin-A signaling targets the small GTPase Rac1, which is known to regulate F-actin remodeling and to modulate glucose-stimulated insulin secretion (Li et al., 2004) . Interestingly, Rac1 was found to be activated by ephrin-A5 reverse signaling and inhibited by EphA5 forward signaling, consistent with opposing effects of EphA5 and ephrin-A5 on glucose-stimulated insulin secretion.
G l u c o s e -s t i m u l a t e d insulin secretion relies on the metabolism of glucose by glycolysis and the tricarboxylic acid cycle (TCA) to generate ATP. An increase in ATP closes ATP-sensitive K + channels, which in turn depolarizes the plasma membrane, thus opening voltage-gated L-type Ca 2+ channels and facilitating insulin secretion. How does Eph-ephrin mediate the effects of glucose on insulin secretion? Konstantinova et al. (2007) found that shortly after glucose stimulation, EphA5 phosphorylation decreased in both islets and MIN6 β cells. This modification alleviated the inhibitory effects of EphA5 forward signaling on insulin secretion. Thus, under basal conditions, EphA forward signaling suppressed insulin secretion, and at high glucose concentrations, dephosphorylation of EphA causes the ephrin reverse signaling to be favored, thereby promoting insulin secretion. In this scenario, it is not clear whether the glucose-stimulated dephosphorylation of EphA5 involves the activation of a specific protein tyrosine phosphatase, and how this modification modulates insulin secretion is also unknown. Furthermore, given that most of the experiments in this report have used an insulinomaderived β cell line, it will be important to confirm these mechanisms in intact human islets. A logical next step would be to evaluate the physi- Insulin secretion from pancreatic β cells is largely dependent on ambient glucose concentration. EphA forward signaling and ephrin-A reverse signaling inhibit and promote insulin secretion, respectively (Konstantinova et al., 2007) . In the presence of glucose, EphA (blue) is dephosphorylated and ephrin-A (green) reverse signaling predominates, thereby promoting insulin secretion by an as yet unknown mechanism. β cells also communicate with each other and neighboring α cells through the action of secreted insulin on insulin receptors. Question marks indicate potential crosstalk between Eph-ephrin signaling and the insulin receptor tyrosine kinase (yellow) for communication within and between insulin-secreting β cells and glucagon-secreting α cells. PTP, phosphotyrosine phosphatase. ological significance of the Ephs and ephrins in insulin secretion in vivo by creating and characterizing β cellspecific inducible knockouts of specific Ephs and/or ephrins. It is notable that EphA5 is localized to the insulin secretory granule, an organelle that is also associated with ATP-dependent K channels, glucokinase, and the insulin receptor (Geng et al., 2003; Hribal et al., 2003) . Whether the close association between these proteins is necessary for intracrine regulation at the level of the secretory granule is worth investigating.
Glucose-stimulated insulin release typically occurs in two phases-a rapid first phase (2-3 min in the mouse and 10 min in humans) after glucose stimulation and a prolonged second phase that lasts up to 30 min. In contrast to many factors-such as the insulin receptor tyrosine kinase-that regulates the first phase glucose-induced insulin release (Kulkarni et al., 1999) , Eph-ephrin signaling predominantly affects the second phase of insulin release. Another avenue to pursue is whether there might be interaction between these two RTK systems that both regulate β cell function and insulin secretion.
Although a part of the mystery underlying β cell-to-β cell communication has been unraveled, the relevance of these observations to disease needs clarification. Could abnormalities in the expression of Ephs and ephrins contribute to defects in altered insulin secretion or maintenance of β cell mass that are characteristic of type 2 diabetes or other insulin-resistant states? Are there polymorphisms in the genes that code for Ephs and ephrins that are associated with altered glucose homeostasis in humans? Further integrative studies should help define the functions of Ephs and ephrins and their role in diabetes and metabolic diseases.
A number of molecules have been discovered that can inhibit the entry of HIV-1 and other viruses into cells of their host (reviewed in Dimitrov, 2004; Liu et al., 2007) . Perhaps the most well-known are the anti-HIV peptides SJ-2176 (Jiang et al., 1993 and T20 (Wild et al., 1994) derived from the C-terminal heptad repeat region of the viral envelope glycoprotein gp41. T20 remains the only HIV-1 entry inhibitor approved for clinical use by the US Food and Drug Administration. The search for peptides with similar or greater potency and crossreactivity and improved pharmacokinetics has yet to yield additional peptide-based therapeutics of clinical utility. Following the example of T20, research has remained largely focused on peptides derived from viruses. However, human blood plasma contains naturally occurring low-molecularweight protein inhibitors of HIV-1 infection. Although the possibility of finding inhibitory peptides in human blood plasma has long been recognized, until recently the task of identifying them from a mixture of more than one million different peptides and small proteins has been daunting. Now, using a peptide library
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